EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Charles River Laboratories International's Enterprise Value is $14,545 Mil.
Charles River Laboratories International's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $718 Mil. Therefore, Charles River Laboratories International's EV-to-EBIT for today is 20.26.
The historical rank and industry rank for Charles River Laboratories International's EV-to-EBIT or its related term are showing as below:
CRL'
s EV-to-EBIT Range Over the Past 10 Years
Min: 15.45 Med: 21.77 Max: 44.66
Current: 20.26
During the past 13 years, the highest EV-to-EBIT of Charles River Laboratories International was 44.66. The lowest was 15.45. And the median was 21.77.
CRL's EV-to-EBIT is ranked worse than 54.13% of 109
companies
in the Medical Diagnostics & Research industry
Industry Median: 18.95
vs CRL: 20.26
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Charles River Laboratories International's Enterprise Value for the quarter that ended in Dec. 2023 was $14,988 Mil.
Charles River Laboratories International's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $718 Mil. Charles River Laboratories International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.79%.
Charles River Laboratories International EV-to-EBIT Historical Data
The historical data trend for Charles River Laboratories International's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Charles River Laboratories International Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-EBIT
25.46
26.98
39.29
20.54
20.87
Charles River Laboratories International Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBIT
20.54
18.34
18.44
17.00
20.87
Competitive Comparison
For the Diagnostics & Research subindustry, Charles River Laboratories International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charles River Laboratories International EV-to-EBIT Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Charles River Laboratories International's EV-to-EBIT falls into.
Charles River Laboratories International EV-to-EBIT Calculation
Charles River Laboratories International's EV-to-EBIT for today is calculated as:
Charles River Laboratories International's current Enterprise Value is $14,545 Mil.
Charles River Laboratories International's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $718 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International (NYSE:CRL) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Charles River Laboratories International's Enterprise Value for the quarter that ended in Dec. 2023 was $14,988 Mil.
Charles River Laboratories International's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $718 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Charles River Laboratories International's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Charles River Laboratories International (Charles River Laboratories International) Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CRL has been successfully added to your 